Andere Sprachen Hypera S.A.

Aktien

A0Q65D

BRHYPEACNOR0

HYPE3

Pharmazeutika

Markt geschlossen - Sao Paulo Andere Börsenplätze 21:07:45 09.03.2026			% 5 Tage	Veränd. 1. Jan.
21,85 ^BRL	-13,16 %		-3,96 %	-7,26 %

03.02.	Hypera aus Brasilien genehmigt Kapitalerhöhung von bis zu 286 Millionen US-Dollar	RE
29.10.25	Hypera S.A., Q3 2025 Earnings Call, Oct 29, 2025

Andere Sprachen

03.02.	Brazil's Hypera approves capital increase of up to $286 million
03.02.	Hypera S A : Material Fact – Capital Increase
03.02.	Hypera S A : Notice to Shareholders - Capital Increase
02.02.	Brazil in focus as Sanofi’s Medley draws bidders
09.01.	Hypera S A : Calendário de Eventos Corporativos 2026
02.01.	Hypera S.A.(BOVESPA:HYPE3) dropped from Brazil IBRX 50 Index
11.12.	Hypera S A : Dados Econômico-Financeiros
06.11.	Hypera S A : Institutional Presentation - Nov/2025
28.10.25	Hypera S A : Press Release 3T25 (PORT e ENG)
28.10.25	Hypera Q3 recurring net profit 453.9 mln reais vs IBES estimate 412.2 mln reais
28.10.25	Hypera S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
02.10.25	Hypera S A : Institutional Presentation - Out/2025
14.08.25	Hypera S A : Summary from the Minutes of the Board of Directors Meeting
12.08.25	Hypera S A : Notice to Debenture Holders – Optional Total Early Redemption – 11th and 12th Debenture Issuances
07.08.25	Hypera S A : Apresentação de Resultados do 2T25
07.08.25	Hypera S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
07.08.25	Hypera S A : Press Release 2T25 (PORT e ENG)
06.08.25	Hypera Q2 recurring profit 426.1 mln reais vs IBES estimate 368.2 mln reais
01.08.25	EMS de Brasil venderá inyectores para tratar la obesidad
01.08.25	Brazil's EMS to sell injector pens to treat obesity
07.07.25	Brazil's Hypera announces new majority stakeholder group
08.05.25	Tranche Update on Hypera S.A.'s Equity Buyback Plan announced on March 13, 2024.
06.05.25	Hypera S A : Board of Directors - Summary of Decisions
24.04.25	Hypera S A : Aviso aos Acionistas - Adoção do processo de voto múltiplo
24.04.25	Trade shift could bring down costs for Brazil's Hypera